<code id='25FD520E39'></code><style id='25FD520E39'></style>
    • <acronym id='25FD520E39'></acronym>
      <center id='25FD520E39'><center id='25FD520E39'><tfoot id='25FD520E39'></tfoot></center><abbr id='25FD520E39'><dir id='25FD520E39'><tfoot id='25FD520E39'></tfoot><noframes id='25FD520E39'>

    • <optgroup id='25FD520E39'><strike id='25FD520E39'><sup id='25FD520E39'></sup></strike><code id='25FD520E39'></code></optgroup>
        1. <b id='25FD520E39'><label id='25FD520E39'><select id='25FD520E39'><dt id='25FD520E39'><span id='25FD520E39'></span></dt></select></label></b><u id='25FD520E39'></u>
          <i id='25FD520E39'><strike id='25FD520E39'><tt id='25FD520E39'><pre id='25FD520E39'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:1844
          Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT
          Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

          WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

          The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

          advertisement

          The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          R1 RCM gets $5.8 billion buyout offer from private equity firm
          R1 RCM gets $5.8 billion buyout offer from private equity firm

          AdobeR1RCM,alargepubliclytradedtechnologycompanythathelpshospitalsandphysicianscollectmoneyfrominsur

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

          MollyFerguson/STATThisweek,anencouragingturnaroundforOcularTherapeutix,achatwithAlnylam’sCEOdefendin